Shareholders' Deficit (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Details
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares Authorized	200,000,000	200,000,000
Nanosynthesis common stock	748,500
Sale of subsidiary common stock	$ 315,000
Nanosynthesis common stock Issued 1	315,000
Sale of subsidiary common stock - related party	$ 110,000	$ 0
Nanosynthesis common stock Issued 2	110,000
Exchange of related party advances with ownership in subsidiary	$ 100,000
Nanosynthesis common stock Issued 3	100,000
Exchange of accounts payable with ownership in subsidiary	$ 7,500
Nanosynthesis common stock Issued 4	7,500
Fair value of subsidiary shares issued for services	$ 216,035	0
Nanosynthesis common stock Issued 5	216,035
Subscriptions receivable	$ 165,000	$ 0
Common Stock Subscriptions Related Parties	5,000
Stockholders' Equity Attributable to Noncontrolling Interest	$ 155,979
Sale of Company common stock in connection with subsidiary transactions	74,854
Related Party shares issued	21,000